LBx Probe ALK C1156Y

LBx Probe ALK C1156Y

※お見積りはログイン後になります。登録がお済でない方はこちらより会員登録を行ってください。

Product Information

Target Mutation p.C1156Y
製品番号 (旧製品番号) A067 (65102)
Detection Typing
Volume Sufficient for 50 reactions
Buffer Low TE
Storage Conditions 4℃
Samples for cfDNA, gDNA (except DNA extracted from FFPE)
Application Digital PCR

Quality Control

文献・学会発表

Takeshita T. et al., Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer, Mol Cancer. 2018 Feb 26;17(1):67.
PMID:29482551, DOI: 10.1186/s12943-018-0808-y


Takeshita T. et al., Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients, BMC Cancer. 2017 Nov 22;17(1):786.
PMID:29166868, DOI:10.1186/s12885-017-3779-2


Yamaoka T. et al., Distinct Afatinib Resistance Mechanisms Identified in LungAdenocarcinoma Harboring an EGFR Mutation, Mol Cancer Res. 2017 Jul;15(7):915-928.
PMID:28289161, DOI:10.1158/1541-7786.MCR-16-0482


Takeshita T. et al., Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients, Oncotarget, 2017 Jun 14;(32):52142-52155.
PMID:28881720, DOI:10.18632/oncotarget.18479

研究用試薬検索

キーワードから探す